A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer (Q40170491)
Jump to navigation
Jump to search
scientific article published on February 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer |
scientific article published on February 2015 |
Statements
1 reference
A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer (English)
1 reference
Rebecca L Prue
Frank Vari
Kristen J Radford
Hui Tong
Rachael D'Rozario
Nigel J Waterhouse
Tony Rossetti
Robert Coleman
Christopher Tracey
Hans Goossen
Vinay Gounder
Georgina Crosbie
Sonia Hancock
Stephanie Diaz-Guilas
Paul Mainwaring
Peter Swindle
1 February 2015
1 reference